Literature DB >> 31983072

Scientific and Regulatory Considerations for an Ontogeny Knowledge Base for Pediatric Clinical Pharmacology.

Gilbert J Burckart1, Shirley Seo1, Aaron C Pawlyk2, Susan K McCune3, Lynne P Yao4, George P Giacoia2, Yaning Wang1, Issam Zineh1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31983072      PMCID： PMC7875197          DOI： 10.1002/cpt.1763

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.903


× No keyword cloud information.
  10 in total

1.  ADMETNet: The knowledge base of pharmacokinetics and toxicology network.

Authors:  Quan Xu; Ke Liu; Xingming Lin; Yangmei Qin; Linshan Chen; Jiao Cheng; Mindong Zhong; Qiushun He; Yinbo Li; Tingwu Wang; Jianbo Pan; Menglu Peng; Lixia Yao; Zhiliang Ji
Journal:  J Genet Genomics       Date:  2017-05-03       Impact factor: 4.275

2.  Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics.

Authors:  Cécile Ollivier; Andrew Thomson; Efthymios Manolis; Kevin Blake; Kristin E Karlsson; Catherijne A J Knibbe; Gérard Pons; Robert Hemmings
Journal:  Br J Clin Pharmacol       Date:  2019-02-28       Impact factor: 4.335

3.  A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration.

Authors:  Xiaomei I Liu; Paul Schuette; Gilbert J Burckart; Dionna J Green; Julie La; Janelle M Burnham; Natella Rakhmanina; Adelaide Robb; Shiew Mei Huang; John N van den Anker
Journal:  J Pediatr       Date:  2019-01-21       Impact factor: 4.406

4.  Pediatric Drug Development: Outlook for Science-Based Innovation.

Authors:  Dionna J Green; Issam Zineh; Gilbert J Burckart
Journal:  Clin Pharmacol Ther       Date:  2018-01-31       Impact factor: 6.875

5.  Pediatric Ontogeny: Moving From Translational Science to Drug Development.

Authors:  Gilbert J Burckart; John N van den Anker
Journal:  J Clin Pharmacol       Date:  2019-09       Impact factor: 3.126

Review 6.  Predictive Pediatric Modeling and Simulation Using Ontogeny Information.

Authors:  Ibrahim Ince; Juri Solodenko; Sebastian Frechen; André Dallmann; Christoph Niederalt; Jan Schlender; Rolf Burghaus; Jörg Lippert; Stefan Willmann
Journal:  J Clin Pharmacol       Date:  2019-09       Impact factor: 3.126

7.  Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events.

Authors:  J M Hill; D V Agoston; P Gressens; S K McCune
Journal:  J Comp Neurol       Date:  1994-04-08       Impact factor: 3.215

Review 8.  Incorporating Ontogeny in Physiologically Based Pharmacokinetic Modeling to Improve Pediatric Drug Development: What We Know About Developmental Changes in Membrane Transporters.

Authors:  Kit Wun Kathy Cheung; Bianca D van Groen; Gilbert J Burckart; Lei Zhang; Saskia N de Wildt; Shiew-Mei Huang
Journal:  J Clin Pharmacol       Date:  2019-09       Impact factor: 3.126

Review 9.  Pediatric Renal Ontogeny and Applications in Drug Development.

Authors:  Yifei Zhang; Neha Mehta; Edit Muhari-Stark; Gilbert J Burckart; John van den Anker; Jian Wang
Journal:  J Clin Pharmacol       Date:  2019-09       Impact factor: 3.126

10.  Real-World Data for Pediatric Pharmacometrics: Can We Upcycle Clinical Data for Research Use?

Authors:  Sara L Van Driest; Leena Choi
Journal:  Clin Pharmacol Ther       Date:  2019-04-03       Impact factor: 6.875
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.